Skip to main content
. 2019 Mar 15;17(6):4928–4934. doi: 10.3892/ol.2019.10150

Figure 3.

Figure 3.

Survival curve analysis of the prognostic value of serum neighboring enhancer of FOXA2 for laryngeal squamous cell carcinoma.